191 related articles for article (PubMed ID: 29752132)
1. Density fluctuations in amorphous pharmaceutical solids. Can SAXS help to predict stability?
Laggner P; Paudel A
Colloids Surf B Biointerfaces; 2018 Aug; 168():76-82. PubMed ID: 29752132
[TBL] [Abstract][Full Text] [Related]
2. Solid-State Reactivity of Mechano-Activated Simvastatin: Atypical Relation to Powder Crystallinity.
Modhave D; Laggner P; Brunsteiner M; Paudel A
J Pharm Sci; 2019 Oct; 108(10):3272-3280. PubMed ID: 31173762
[TBL] [Abstract][Full Text] [Related]
3. Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin.
Graeser KA; Patterson JE; Rades T
Curr Drug Deliv; 2009 Aug; 6(4):374-82. PubMed ID: 19534709
[TBL] [Abstract][Full Text] [Related]
4. Small- and wide-angle X-ray scattering (SWAXS) for quantification of aspirin content in a binary powder mixture.
Hodzic A; Llusa M; Fraser SD; Scheibelhofer O; Koller DM; Reiter F; Laggner P; Khinast JG
Int J Pharm; 2012 May; 428(1-2):91-5. PubMed ID: 22425676
[TBL] [Abstract][Full Text] [Related]
5. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
[TBL] [Abstract][Full Text] [Related]
6. Specific surface, crystallinity, and dissolution of lyophilized fibrinogen. A study by combined small- and wide-angle X-ray scattering (SWAXS).
Wahl V; Saurugger E; Khinast J; Laggner P
Eur J Pharm Biopharm; 2015 Jan; 89():374-82. PubMed ID: 25536110
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
8. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.
Bates S; Zografi G; Engers D; Morris K; Crowley K; Newman A
Pharm Res; 2006 Oct; 23(10):2333-49. PubMed ID: 17021963
[TBL] [Abstract][Full Text] [Related]
9. The use of molecular descriptors in the development of co-amorphous formulations.
Meng-Lund H; Kasten G; Jensen KT; Poso A; Pantsar T; Rades T; Rantanen J; Grohganz H
Eur J Pharm Sci; 2018 Jul; 119():31-38. PubMed ID: 29649569
[TBL] [Abstract][Full Text] [Related]
10. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
[TBL] [Abstract][Full Text] [Related]
11. Laser irradiation to produce amorphous pharmaceuticals.
Titapiwatanakun V; Tankul J; Basit AW; Gaisford S
Int J Pharm; 2016 Nov; 514(1):282-289. PubMed ID: 27863673
[TBL] [Abstract][Full Text] [Related]
12. Critical considerations for the qualitative and quantitative determination of process-induced disorder in crystalline solids.
Newman A; Zografi G
J Pharm Sci; 2014 Sep; 103(9):2595-2604. PubMed ID: 24623166
[TBL] [Abstract][Full Text] [Related]
13. On the amorphous layer in bone mineral and biomimetic apatite: A combined small- and wide-angle X-ray scattering analysis.
Bertolotti F; Carmona FJ; Dal Sasso G; Ramírez-Rodríguez GB; Delgado-López JM; Pedersen JS; Ferri F; Masciocchi N; Guagliardi A
Acta Biomater; 2021 Jan; 120():167-180. PubMed ID: 32438109
[TBL] [Abstract][Full Text] [Related]
14. [Amorphization in pharmaceutical technology].
Révész P; Laczkovich O; Eros I
Acta Pharm Hung; 2004; 74(1):39-44. PubMed ID: 15524047
[TBL] [Abstract][Full Text] [Related]
15. Comparison of amorphous states prepared by melt-quenching and cryomilling polymorphs of carbamazepine.
Guinet Y; Paccou L; Danède F; Willart JF; Derollez P; Hédoux A
Int J Pharm; 2016 Jul; 509(1-2):305-313. PubMed ID: 27237427
[TBL] [Abstract][Full Text] [Related]
16. Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acids.
Curtin V; Amharar Y; Gallagher KH; Corcoran S; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2013 Nov; 456(2):508-16. PubMed ID: 23994365
[TBL] [Abstract][Full Text] [Related]
17. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
[TBL] [Abstract][Full Text] [Related]
18. Solid-state (13)C NMR and synchrotron SAXS/WAXS studies of uniaxially-oriented polyethylene.
Afeworki M; Brant P; Lustiger A; Norman A
Solid State Nucl Magn Reson; 2015 Nov; 72():27-40. PubMed ID: 26476811
[TBL] [Abstract][Full Text] [Related]
19. Micro- and nanoscale structures of mesiodens dentin: Combined study of FTIR and SAXS/WAXS techniques.
Akgun OM; Bayari SH; Ide S; Polat GG; Kalkhoran IO
Microsc Res Tech; 2015 Jan; 78(1):52-8. PubMed ID: 25327575
[TBL] [Abstract][Full Text] [Related]
20. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
